|
ICANL accreditation is offered in the following testing areas:
NUCLEAR CARDIOLOGY
- Myocardial Perfusion Imaging
- Equilibrium Radionuclide Angiography
- Cardiac PET Imaging
- Other Cardiovascular Imaging
NUCLEAR MEDICINE
- Gastrointestinal System Imaging
- Central Nervous System Imaging
- Endocrine System Imaging
- Endocrine System Nonimaging (e.g. radioiodine uptake)
- Skeletal System Imaging
- Genitourinary System Imaging
|
- Pulmonary System Imaging
- Infection Imaging
- Tumor Imaging
- Hematopoietic, Reticuloendothelial and Lymphatic Imaging
- Nuclear Medicine Therapy
|
POSITRON EMISSION TOMOGRAPHY (PET)
- Oncologic Imaging
- Neurologic Imaging
- Cardiac Imaging
The Accreditation Process
Nuclear medicine laboratories seeking accreditation by the ICANL participate via a two-step process. First, a thorough review of the ICANL Standards enables staff to be familiar with the published requirements and recommendations for the performance and interpretation of quality nuclear medicine testing. Staff members are encouraged to make any necessary changes to the laboratory’s operations to ensure at a minimum, substantial compliance to the Standards before proceeding to completion of the application. The corresponding ICANL Online Accreditation application allows participating laboratories to answer questions and submit data and attachments to document compliance with the Standards. The submission of sample case studies and their corresponding final reports is a heavily weighted component of the application process.
Accreditation Decisions
Each application submitted to the ICANL undergoes a simultaneous, independent review conducted by two application reviewers. Read more about the process»
The ICANL Board of Directors reviews the findings and renders an accreditation decision:
- Grant
- Delay
- Site Visit
- Deny (No application for accreditation is ever initially denied; laboratories first receive a notification of a delay or a site visit).
The ICANL advises each laboratory of its accreditation decision via a personalized notification letter. This letter, sent to the Medical and Technical Directors, details the accreditation decision and when required, requests any additional documentation to further support adherence to the ICANL Standards. Read more about the various accreditation decisions»
Maintaining Compliance — Random Site Visits & Audits
In an effort to further substantiate continued compliance by accredited laboratories and in response to the requirements sanctioned by the Centers for Medicare & Medicaid Services (CMS) for CMS appointed Accreditation Organizations as part of the Medicare Improvements for Patients and Providers Act (MIPPA), the IAC has implemented a policy requiring all accredited laboratories to undergo an audit or site visit at some time during their three-year accreditation period. Read more about random site visits and audits»
IAC Agreement
Effective 1/1/10: Applications submitted to the IAC must be accompanied by a current, completed IAC Accreditation Agreement (current published version is 8/2011) in order to receive an accreditation decision. Obtain instructions, read important information and download the IAC Agreement on the IAC website»
Accreditation Fee
Access to ICANL Online Accreditation is now free of charge. Applicant laboratories are only charged the accreditation fee, due at the time of application submission.
Read more about Accreditation Fees»
Laboratories with Multiple Sites (Fixed and/or Mobile)
The ICANL provides a pathway for eligible facilities with multiple sites (fixed and/or mobile) to apply for accreditation with one application and reduced fees for additional sites.
Read more about Multiple Sites»
|
